Warning letter
Amcyte Pharma: warning letter of Jan 3, 2022
FDA warning letter 623474
Key facts
| Reference number | 623474 |
|---|---|
| Company | Amcyte Pharma |
| Issue date | Jan 3, 2022 |
| Posted date | Jan 4, 2022 |
| Product type | Drugs |
| Country | 1 |
| Letter on fda.gov | fda.gov |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: